Lower PTEN expression was observed in drug-resistant CML cells; consistent with our reports in human embryonic stem cells, the over-expression of ABCG2 in H9 cells leads to p-Akt activation [38]. This evidence concerns the gene ABCG2 and chronic myelogenous leukemia, BCR-ABL1 positive.